Chemoinformaics analysis of Ethyl (E)-hept-4-enoate
| Molecular Weight | 156.225 | nRot | 5 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 2 |
| Exact Molecular Weight | 156.115 | nRing | 0 |
| Solubility: LogS | -2.945 | nHRing | 0 |
| Solubility: LogP | 2.758 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.3027 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.451 |
| Synth | 2.2 |
| Natural Product Likeliness | 1.259 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.293 |
| MDCK | 0.0000514 |
| BBB | 0.982 |
| PPB | 0.879911 |
| VDSS | 0.896 |
| FU | 0.11596 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.425 |
| CYP2c19-inh | 0.594 |
| CYP2c19-sub | 0.515 |
| CYP2c9-inh | 0.192 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.125 |
| CYP2d6-sub | 0.376 |
| CYP3a4-inh | 0.101 |
| CYP3a4-sub | 0.206 |
| CL | 6.25 |
| T12 | 0.893 |
| hERG | 0.022 |
| Ames | 0.003 |
| ROA | 0.026 |
| SkinSen | 0.85 |
| Carcinogencity | 0.197 |
| EI | 0.984 |
| Respiratory | 0.097 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.950222 |